79378-230 : Livmarli 30 mg Oral Tablet
| NDC: | 79378-230 |
| Labeler: | Mirum Pharmaceuticals Inc. |
| Product Type: | Human Prescription Drug |
| Drug Name: |  Livmarli |
| Dosage Form: | Oral Tablet |
| Application #: | NDA219485 |
| Rev. Date: |
NDC Package Codes:
- 79378-230-30: 1 BOTTLE IN 1 CARTON (79378‑230‑30) / 30 TABLET IN 1 BOTTLE
Active Ingredients:
- Maralixibat Chloride
Dosage Strength:
- 30 mg
Pharmaceutical Classes:
- Ileal Bile Acid Transporter Inhibitor [EPC]
- Ileal Bile Acid Transporter Inhibitors [MoA]
- Organic Anion Transporting Polypeptide 2B1 Inhibitors [MoA]
Related Products:
Based on records with the same trade name.- 79378-110 Livmarli 9.5 mg/ml Oral Solution by Mirum Pharmaceuticals Inc.
- 79378-111 Livmarli 19 mg/ml Oral Solution by Mirum Pharmaceuticals Inc.
- 79378-210 Livmarli 10 mg Oral Tablet by Mirum Pharmaceuticals Inc.
- 79378-215 Livmarli 15 mg Oral Tablet by Mirum Pharmaceuticals Inc.
- 79378-220 Livmarli 20 mg Oral Tablet by Mirum Pharmaceuticals Inc.
NDC QR Code
Scan the QR code below to easily reference this data in the future:
< Prev: 79378-220Next: 79378-310 >
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.